CLINICAL_TRIALS
trial_result
· 2015-04-02
Clinical Trial Update: Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia [Phase 3]
Summary
Phase 3 clinical trial evaluating the efficacy and safety of oral aripiprazole in adolescents with schizophrenia has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2015-04-02